Reducing liquid handling errors with INTEGRA Biosciences’ range of pipettes
INTEGRA’s range of ergonomic pipettes can help to maintain consistent pipetting angles
INTEGRA’s range of ergonomic pipettes can help to maintain consistent pipetting angles
Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials
The new electronic ErgoOne E 8 and 12 channel pipettes have a volume range of 50–1250 µL
Agilent Technologies, Thermo Fisher Scientific, and Tecan among those recognized
firefly®+ delivers compact and intuitive benchtop instrument
The new no-code protocol library and AI-powered protocol generation tools provides scientists with automated workflows
Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling
Experts at the University of Nottingham have discovered how to create different colors of blue cheese
The Echo MS+ system unlocks enhanced high-throughput screening capability
New platform now available for therapeutics development teams
A cutting-edge, high-density, energy efficient, automated sample storage system
Discover which products have earned a coveted Seal of Quality award
Researchers from Imperial College London have shown that a blood test can pinpoint the underlying cause of brain injury in newborns
New study findings from the University of Manchester are important for the development of new wound therapies
Automated workflows from single-cell dispensing to 3D spheroid analysis
Showcase will include more than 40 products from its life sciences and diagnostics protfolio
New system enables advanced analysis of live cell cultures with high-definition, high-speed 3D imaging
Latest digital product releases promise to enhance lab productivity
Visit our new Cell and Gene Therapy Accelerating Science feature to explore the remarkable achievements in the field and investigate the possibilities ahead
New off-the-shelf system reduces the cost and risk of lentiviral production for cell and gene therapy developers